Dr. Kenneth A. Beckman, MD

Dr. Beckman practices at Comprehensive Eyecare of Central OH, Inc in Westerville, Ohio.

Dr. Beckman's NPI, 1699731018, was assigned on April 25, 2006. Dr. Beckman graduated from Ohio State College of Medicine in 1991. Dr. Beckman holds Ohio license 35064674B.

Dr. Beckman's primary practice is Comprehensive Eyecare of Central OH, Inc, at 450 Alkyre Run Dr, Westerville, OH 43082 in Delaware County. The practice phone is (614) 890-5692.

Dr. Beckman's primary practice is Comprehensive Eyecare of Central OH, Inc in Westerville, Ohio. Dr. Beckman is also affiliated with Mount Carmel East. Dmand AI also links Dr. Beckman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beckman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Beckman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Beckman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Beckman's licenses on file in 2 states: Ohio and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Beckman treats.

CMS data shows 3,140 Medicare services from Dr. Beckman across 16 procedure codes in 2024, for 689 Medicare patients. Medicare paid $206,496 for them.

CMS counts 689 Medicare patients who saw Dr. Beckman in 2024. The largest group is 65 to 74, with 321 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beckman's median patient age at 71, with 55% women.

In 2024, Dr. Beckman wrote 2,439 Medicare Part D claims for 669 patients. 51% of them were for generic drugs. CMS names the drug for 2,307 of them, across 26 drugs with 11 or more claims each, at $628,021 in total drug cost. In 2023, CMS named 1,855 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Beckman for performance year 2024, reported as part of a group. Dr. Beckman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 268 procedures of cataract surgery by Dr. Beckman, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Beckman, published from 2018 to 2023. 2020 was the busiest year, with 3. The most frequent topics are Inflammation, Anti-Allergic Agents and Cornea. Dr. Beckman has published most often in J Cataract Refract Surg. Dr. Beckman's most frequent co-authors are Preeya Kshettry Gupta, MD, Terry Kim, MD and Francis S. Mah, MD.

Dmand AI links Dr. Beckman to 4 clinical trials, 2 of them phase 3 studies. Conditions studied include Keratoconus, Corneal Diseases and Dry Eye Syndromes.

CMS Open Payments shows 983 general payments to Dr. Beckman from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Bausch & Lomb Americas Inc. paid the most, $107,592.

Dmand AI lists 2 awards for Dr. Beckman.

Dr. Beckman graduated from Ohio State College of Medicine in 1991. Dr. Beckman is a member of AAO and ACS.

Dr. Beckman is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.